60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.169
-0.001 (-0.12%)
Sep 28, 2026, 10:22 AM EDT - Market open
SXTP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.21 | 1.41 | 0.68 | 0.25 | 0.51 | 6.35 | |
Revenue Growth | 23.41% | 106.81% | 168.70% | -50.40% | -91.95% | 149.18% |
Cost of Revenue | 3.28 | 2.89 | 5.37 | 0.67 | 0.96 | 6.36 |
Gross Profit | -2.06 | -1.48 | -4.69 | -0.41 | -0.45 | -0.01 |
Selling, General & Admin | 6.54 | 6.28 | 5.03 | 4.24 | 1.3 | 1.12 |
Research & Development | - | - | - | 0.5 | - | - |
Operating Expenses | 6.54 | 6.28 | 5.03 | 4.74 | 1.3 | 1.12 |
Operating Income | -8.61 | -7.76 | -9.72 | -5.15 | -1.75 | -1.12 |
Interest Expense | -0.03 | -0.01 | -0.01 | -2.29 | -3.99 | -3.17 |
Other Non Operating Income (Expenses) | 0.53 | 0.4 | 1.77 | -0.47 | -0.56 | -0 |
EBT Excluding Unusual Items | -8.11 | -7.37 | -7.96 | -7.91 | -6.3 | -4.3 |
Other Unusual Items | - | - | - | 4.1 | 0.12 | 0.04 |
Pretax Income | -8.11 | -7.37 | -7.96 | -3.81 | -6.18 | -4.26 |
Income Tax Expense | - | - | - | 0 | 0 | 0 |
Earnings From Continuing Operations | -8.11 | -7.37 | -7.96 | -3.81 | -6.18 | -4.26 |
Minority Interest in Earnings | 0 | 0 | 0.01 | 0.05 | -0 | 0.01 |
Net Income | -8.11 | -7.37 | -7.95 | -3.77 | -6.18 | -4.25 |
Preferred Dividends & Other Adjustments | 0.52 | 0.5 | 0.48 | 0.22 | - | - |
Net Income to Common | -8.62 | -7.87 | -8.43 | -3.99 | -6.18 | -4.25 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | - | 19 |
Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | - | 19 |
Shares Change | 506.60% | 489.64% | 585.60% | - | - | - |
EPS (Basic) | -5.41 | -11.74 | -74.17 | -240.45 | - | -0.23 |
EPS (Diluted) | -5.41 | -11.74 | -74.17 | -240.45 | - | -0.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.89 | -6.99 | -5.75 | -4.6 | -1.01 | -0.65 |
Free Cash Flow Per Share | -5.58 | -10.43 | -50.60 | -277.49 | - | -0.04 |
Gross Margin | -169.87% | -104.94% | - | -163.01% | -87.39% | -0.14% |
Operating Margin | -708.47% | -550.61% | -1425.88% | -2032.78% | -342.41% | -17.69% |
Profit Margin | -709.87% | -558.25% | -1237.32% | -1572.10% | -1209.23% | -66.93% |
Free Cash Flow Margin | -732.12% | -495.99% | -844.19% | -1814.28% | -197.57% | -10.27% |
EBITDA | -8.5 | -7.68 | -9.66 | -5.1 | -1.72 | -1.09 |
EBITDA Margin | - | - | - | - | - | -17.21% |
D&A For EBITDA | 0.1 | 0.08 | 0.05 | 0.05 | 0.03 | 0.03 |
EBIT | -8.61 | -7.76 | -9.72 | -5.15 | -1.75 | -1.12 |
EBIT Margin | - | - | - | - | - | -17.69% |